SAM SADEGHI: Open Payments
NPI 1053380949 · KINGSPORT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,128 in 115 payments from 27 companies in 2025. Trend: 2023 $2,150 · 2024 $2,510 · 2025 $2,128
Food & beverage: $2,128
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $350 |
| ABBVIE INC. | 18 | $255 |
| Novo Nordisk Inc | 18 | $254 |
| GlaxoSmithKline, LLC. | 16 | $215 |
| PFIZER INC. | 12 | $172 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $101 |
| Lilly USA, LLC | 6 | $99 |
| Boston Scientific Corporation | 2 | $76 |
| Axsome Therapeutics, Inc. | 3 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $62 |
Products named: FARXIGA, TRELEGY ELLIPTA, Ozempic, VRAYLAR, NURTEC ODT, CAPLYTA, QULIPTA, BREZTRI.
Industry payments across TN — which companies pay providers there.
